Deep-pocketed investors have adopted a bullish approach towards Doximity DOCS, and it’s something market players shouldn’t ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in DOCS usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga’s options scanner highlighted 15 extraordinary options activities for Doximity. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 60% leaning bullish and 33% bearish. Among these notable options, 12 are puts, totaling $2,078,849, and 3 are calls, amounting to $121,942.
What’s The Price Target?
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $20.0 to $70.0 for Doximity during the past quarter.
Volume & Open Interest Trends
In today’s trading context, the average open interest for options of Doximity stands at 1078.42, with a total volume reaching 6,103.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Doximity, situated within the strike price corridor from $20.0 to $70.0, throughout the last 30 days.
Doximity 30-Day Option Volume & Interest Snapshot
Biggest Options Spotted:
Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
---|---|---|---|---|---|---|---|---|---|---|---|
DOCS | PUT | SWEEP | BULLISH | 01/16/26 | $22.0 | $21.9 | $22.0 | $70.00 | $1.3M | 560 | 602 |
DOCS | PUT | TRADE | BULLISH | 05/16/25 | $11.1 | $10.0 | $10.28 | $60.00 | $123.3K | 1.7K | 238 |
DOCS | PUT | TRADE | BULLISH | 05/16/25 | $11.4 | $11.1 | $11.2 | $60.00 | $112.0K | 1.7K | 214 |
DOCS | PUT | TRADE | BEARISH | 06/20/25 | $11.2 | $10.4 | $10.9 | $60.00 | $104.6K | 368 | 146 |
DOCS | PUT | SWEEP | BULLISH | 05/16/25 | $1.7 | $1.65 | $1.65 | $50.00 | $98.1K | 3.0K | 335 |
About Doximity
Doximity Inc is a digital platform for U.S. medical professionals. Its cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers.
Doximity’s Current Market Status
- Trading volume stands at 13,627,945, with DOCS’s price down by -17.86%, positioned at $48.01.
- RSI indicators show the stock to be is currently neutral between overbought and oversold.
- Earnings announcement expected in 83 days.
What Analysts Are Saying About Doximity
In the last month, 5 experts released ratings on this stock with an average target price of $58.8.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access.
* Consistent in their evaluation, an analyst from Morgan Stanley keeps a Equal-Weight rating on Doximity with a target price of $60.
* An analyst from Raymond James has decided to maintain their Outperform rating on Doximity, which currently sits at a price target of $65.
* An analyst from Canaccord Genuity persists with their Hold rating on Doximity, maintaining a target price of $50.
* An analyst from Truist Securities has decided to maintain their Hold rating on Doximity, which currently sits at a price target of $52.
* An analyst from Needham has decided to maintain their Buy rating on Doximity, which currently sits at a price target of $67.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Doximity options trades with real-time alerts from Benzinga Pro.
Add Comment